Abstract: The present invention relates to a novel gene derived from a tidal flat metagenome, and a novel protein obtained therefrom showing the coactivity of phospholipase and lipase. Specifically, the novel gene isolated from the metagenome library of tidal flat sediments and the protein having phospholipase and lipase activities encoded from the novel gene: are expressed in a water-soluble form to be mass-producible; enable ultra high-purity protein to be obtained through single step purification using an Ni-NTA column; show good activity in the pH range of 5˜10; maintain good low temperature activity and stability up to a temperature of 3° C. to 40° C.; and have high resistance against various organic solvents. Therefore, the novel gene and the protein can be usefully used for various industrial fields such as the purification and conversion of oil and fat, bio-medicine, and fine chemistry.

Abstract: A curved multi-view image display apparatus is provided. The curved multi-view image display apparatus includes: a curved display panel which includes a plurality of sub-pixels and has a curvature; a viewing zone divider provided on in front of the display panel and configured to divide a viewing zone and provide a plurality of optical views; a renderer configured to render a multi-view image to be output to the display panel; and a controller configured to determine a rendering pitch for each of the plurality of optical views based on the curvature, and control the renderer so that at least some of the plurality of sub-pixels to output a pixel value corresponding to a plurality of multi-view images based on the determined rendering pitch.

Abstract: The present invention relates to a novel gene derived from a tidal flat metagenome, and a novel protein obtained therefrom showing the coactivity of phospholipase and lipase. Specifically, the novel gene isolated from the metagenome library of tidal flat sediments and the protein having phospholipase and lipase activities encoded from the novel gene: are expressed in a water-soluble form to be mass-producible; enable ultra high-purity protein to be obtained through single step purification using an Ni-NTA column; show good activity in the pH range of 5˜10; maintain good low temperature activity and stability up to a temperature of 3° C. to 40° C.; and have high resistance against various organic solvents. Therefore, the novel gene and the protein can be usefully used for various industrial fields such as the purification and conversion of oil and fat, bio-medicine, and fine chemistry.

Abstract: A display apparatus includes a display panel which includes a plurality of sub pixels each outputting a sub pixel value of R, G, or B, a renderer which renders a multi-view image to be outputted by the display, and a controller which determines a rendering pitch according to a viewing distance of a user, and controls the renderer so that each of at least some of the plurality of sub pixels outputs a combined sub pixel value corresponding to a combination of sub pixel values corresponding to each of the plurality of views of the multi-view image according to the determined rendering pitch.

Abstract: A display apparatus is provided. The display apparatus includes a display panel comprising a plurality of pixels including a plurality of sub-pixels, and arranges and displays a multi-view image in an arrangement pattern. The display panel includes a polarizing film disposed on a back surface of the display panel and which transmits, to the display panel, light having a first polarization direction to an area corresponding to a first part of each of the sub-pixels, and light having a second polarization direction to an area corresponding to a second part of the sub-pixels. a polarizing panel disposed on a back surface of the polarizing film and configured to adjusts the first and second polarization directions of the light transmitted by the polarizing film, and a controller configured to control a driving state of the polarizing panel to sequentially provide the first and second polarization directions for one image frame section.

Abstract: The present invention relates to a pheophorbide-? conjugate or its salt, solvate or hydrate. The pheophorbide-? conjugate of the present invention exhibiting fluorescence upon its introduction into cells and degradation inhibits the survival of various cancer cells. Especially, the conjugate of pheophorbide-? (1) and doxorubicin shows higher fluorescence intensity at lower pH (cancer environment). Therefore, the present composition for photodynamic therapy (PDT) of cancers is also very useful in detecting cancers. Interestingly, the anticancer effects of the present composition are dually exerted with help of both the photosensitizer and the anticancer drug of the present conjugates.

Abstract: A display apparatus includes a display panel configured to display an image frame that includes a right-eye image and a left-eye image, and a touch panel configured to sense a user touch, wherein the touch panel includes a polarizing switch panel configured to switch a direction of polarization of light emitted from the display panel, and a parallax realization layer which is formed on one side of the polarizing switch panel and is configured to provide a binocular disparity image by using light emitted from the polarizing switch panel.

Abstract: A display apparatus includes a display panel which includes a plurality of sub pixels each outputting a sub pixel value of R, G, or B, a renderer which renders a multi-view image to be outputted by the display, and a controller which determines a rendering pitch according to a viewing distance of a user, and controls the renderer so that each of at least some of the plurality of sub pixels outputs a combined sub pixel value corresponding to a combination of sub pixel values corresponding to each of the plurality of views of the multi-view image according to the determined rendering pitch.

Abstract: A 3D display apparatus is provided, which includes a display panel which displays a multi-viewpoint image, a barrier arranged on one side of the display panel unit, and a controller which controls the barrier to alternately form light transmitting areas and light blocking areas. The barrier includes a liquid crystal layer, a plurality of upper electrodes arranged to be spaced apart from one another on an upper surface of the liquid crystal layer, and a plurality of lower electrodes arranged to be spaced apart from one another on a lower surface of the liquid crystal layer.

Abstract: A 3D display device includes: a data processor configured to generate at least one frame by combining a left-eye image and a right-eye image; a panel including pixels, each of the pixels including three sub pixels; a barrier configured to form a light blocking region and a light transmitting region on the panel on a basis of two sub pixel units; and a controller configured to control the data processor to generate the at least one frame by placing the left-eye image and the right-eye image alternately on the basis of two sub pixels, and to control the panel to display at least one frame generated by the data processor.

Abstract: Provided are G12 human rotaviruses having VP7 gene of SEQ ID NO: 1 or 2 and VP4 gene of SEQ ID NO: 3 or 4; antibodies specific for said rotaviruses; and a vaccine composition containing the same. The antibodies and the vaccine composition are effective for diagnosing rotavirus infection and for treatment of diseases caused by rotavirus.

Abstract: A method of controlling a liquid crystal display (LCD) device including an LCD panel and an edge-type backlight unit is provided. The method includes: controlling turn-on and turn-off periods of an upper light source unit and a lower light source unit of the edge-type backlight unit to be synchronized with a period during which a 3D image is output on the LCD panel, wherein the upper light source unit includes a light source disposed at an upper edge of the edge-type backlight unit, and the lower light source unit includes a light source disposed at a lower edge of the edge-type backlight unit.

Abstract: Provided are G12 human rotaviruses having VP7 gene of SEQ ID NO: 1 or 2 and VP4 gene of SEQ ID NO: 3 or 4; antibodies specific for said rotaviruses; and a vaccine composition containing the same. The antibodies and the vaccine composition are effective for diagnosing rotavirus infection and for treatment of diseases caused by rotavirus.

Abstract: The present invention relates to an indirubin derivative having anticancer property by inhibiting cell proliferation as to human cancer cell line. More particularly, this invention provides the synthesis of indirubin derivative known as CDK(Cyclin-dependent kinase) inhibitor. Further, inhibition activity of proliferation as to human cancer cell line and apoptosis against induced-differentiation of said indirubin derivative are researched to develop a novel indirubin derivative having efficacious anticancer properties as to various human cell lines.

Abstract: The present invention relates to an indirubin derivative having anticancer property by inhibiting cell proliferation as to human cancer cell line. More particularly, this invention provides the synthesis of indirubin derivative known as CDK(Cyclin-dependent kinase) inhibitor. Further, inhibition activity of proliferation as to human cancer cell line and apoptosis against induced-differentiation of said indirubin derivative are researched to develop a novel indirubin derivative having efficacious anticancer properties as to various human cell lines.

Abstract: The present invention relates to a Lactobacillus reuteri variant from animal sources that inhibits rotavirus infection and other pathogenic microorganisms, as well as being tolerant of gastric and bile acids. Also, this invention relates to a prophylactic and therapeutic composition comprising the same for contributing in many probiotic ways to the host's general health and preventing and treating diseases or conditions associated with rotavirus and other enteric pathogens.

Abstract: The present invention relates to a Lactobacillus reuteri variant from animal sources that inhibits rotavirus infection and other pathogenic microorganisms, as well as being tolerant of gastric and bile acids. Also, this invention relates to a prophylactic and therapeutic composition comprising the same for contributing in many probiotic ways to the host's general health and preventing and treating diseases or conditions associated with rotavirus and other enteric pathogens.